CCNE1 and neoplasm: For example, Chand et al. demonstrated cell growth inhibition and an anti-tumor effect in CCNE1-overexpressed breast cancer cells using INCB123667, a potent and selective small-molecular inhibitor of CDK2 that is currently in clinical development [60].